Parameter
| Biomarker | CD4 count, neutrophil count | Full name | Cluster of differentiation 4 cell count, neutrophil count | Molecular Type | Count of immune cells/cells |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis | ||
| Disease | NHL | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Blood (Complete Blood Count, Flow Cytometry) | ||
| Pathobiological Mechanisms | CD4<150 cells/μL and neutrophilia are associated with poor prognosis | ||||
| Clinical Availability Status | Clinical validation phase: validation of 76 patients, requiring guideline inclusion and protocol stability assessment. | ||||
| Notes and Dynamics | Validation of the era value of immunotherapy and exploration of clinical translation of MO-Y detection. | ||||